Galapagos NV

Most Recent

  • uploads///business _
    Company & Industry Overviews

    Gilead Sciences Expands Collaboration with Galapagos

    On July 14, Gilead Sciences announced that it will expand its collaboration with Galapagos (GLPG).

    By Margaret Patrick
  • Company & Industry Overviews

    What’s behind the Dismal Performance of NBQAX?

    NBQAX has had a terrible 2016 so far. Among its top invested sectors, information technology has been almost inconsequential to its performance.

    By David Ashworth
  • uploads///Graph
    Company & Industry Overviews

    AbbVie Expects to Commercialize Selective JAK1 Inhibitor ABT-494

    Currently being tested in six Phase 3 trials, ABT-494 is expected to be a significant improvement in the standard of care for rheumatoid arthritis.

    By Margaret Patrick
  • Company & Industry Overviews

    Why Has the Nuveen International Growth Fund Stumbled in YTD 2016?

    Through June 17, the Nuveen International Growth Fund – Class A (NBQAX) has figured among the bottom three funds in its peer group of 12 funds.

    By David Ashworth
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.